Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Fuji
QuintilesIMS
Fish and Richardson
Baxter

Generated: August 17, 2019

DrugPatentWatch Database Preview

Chlorpheniramine maleate; codeine phosphate - Generic Drug Details

  Try a free trial


See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chlorpheniramine maleate; codeine phosphate and what is the scope of chlorpheniramine maleate; codeine phosphate patent protection?

Chlorpheniramine maleate; codeine phosphate is the generic ingredient in one branded drug marketed by Mainpointe and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorpheniramine maleate; codeine phosphate has fifty-eight patent family members in eleven countries.

There are twenty-nine drug master file entries for chlorpheniramine maleate; codeine phosphate. Two suppliers are listed for this compound.

Summary for chlorpheniramine maleate; codeine phosphate
Pharmacology for chlorpheniramine maleate; codeine phosphate

US Patents and Regulatory Information for chlorpheniramine maleate; codeine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mainpointe TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Mainpointe TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 RX No No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Mainpointe TUXARIN ER chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 RX No No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Covington
Julphar
Baxter
Citi
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.